Emerging drugs in prostate cancer

Bibliography

• BORING CC, SQUIRES TS, TONG T: Cancer statistics 1993. CA Canced. Clin. (1993) 43:7–26.
   PubMed Web of Science ®Google Scholar
• AMERICAN CANCER SOCIETY: Cancer facts 8z figures - 1997. The Society, Atlanta (1997).
   Google Scholar
• DIJKMAN GA, DEBRUYNE FMJ: Epidemiology of prostate cancer. Eur. Urol. (1996) 30:281–295.
   PubMed Web of Science ®Google Scholar
• BOCCON-GIBOD L: The management of localised cancer of the prostate. Eur. Urol. (1996) 29(Suppl. 2) :62–68.
   PubMed Web of Science ®Google Scholar
• CRAWFORD ED: Combined androgen blockade. Eur. Urol. (1996) 29\(Suppl. 2):54–61.
   PubMed Web of Science ®Google Scholar
• NEWLING DVVVV: The palliative therapy of advanced prostate cancer with particular reference to the results of recent European clinical trials. Br. J. Urol. (1997) 79 (Suppl. 1) :72–81.
   PubMedGoogle Scholar
• ••Comprehensive review of the issues surrounding the treatment of advanced prostate cancer.
   Google Scholar
• HELGASON AR, ADOLFSSON J, DICKMAN P, et al.: Waning sexual function - the most important disease-specific distress for patients with prostate cancer. Br. J. Cancer (1996) 73:1417–1421.
   PubMed Web of Science ®Google Scholar
• FERNANDEZ DEL MORAL P, DIJKMAN GA, DEBRUYNE FMJ, et al.: Three-month depot of goserelin acetate: clinical efficacy and endocrine profile. Urology (1996) 48:894–900.
   PubMed Web of Science ®Google Scholar
• NODA M, TSUSHIMA T, NASU Yet al.: The effect of a gonadotrophin-releasing hormonal agonist on bone mineral density of prostatic cancer patients. J. Urol. (1997) 157. Abstract 907.
   Google Scholar
• NEWLING DWW: Anti-androgens in the treatment of prostate cancer. Br. J. Urol. (1996) 77:776–784.
   PubMedGoogle Scholar
• MCLEOD DG: Tolerability of nonsteroidal antiandrogens in the treatment of advanced prostate cancer. Oncologist (1997) 2: 18–27.
   Google Scholar
• ROBINSON MRG: A further analysis of European Organisation for Research and Treatment of Cancer protocol 30805: orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose diethylstilboestrol. Cancer (1993) 72:3855–3857.
   PubMed Web of Science ®Google Scholar
• RAGHA VAN D, KOCZWARA B, JAVLE M: Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur. J. Cancer (1997) 33:566–574.
   PubMed Web of Science ®Google Scholar
• NEWLING DVVVV: The management of hormone refractory prostate cancer. Eur. Urol. (1996) 29 (Suppl. 2) :69–74.
   PubMed Web of Science ®Google Scholar
• KIRBY RS, CHRISTMAS TJ, BRAWER M: Management of hormone escaped prostate cancer. In: Prostate Cancer. Mosby (1996).
   Google Scholar
• GALBRAITH SM, DUCHESNE GM: Androgens and prostate cancer: biology, pathology and hormonal therapy. Eur. J. Cancer (1997) 33:545–554.
   PubMed Web of Science ®Google Scholar
• SCHELLHAMMER P, SHARIFI R, BLOCK N, et al.: Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostate carcinoma: final report of a double-blind randomised, multicenter trial. Urology (1997) 50:330–336.
   PubMed Web of Science ®Google Scholar
• BLACKLEDGE GRP, COCKSHOTT I, FURR BJA: Casodex (bicalutamide): overview of a new antiandrogen developed for the treatment of prostate cancer. Eur. Urol. (1997) 31: 30–39.
   Google Scholar
• TUNN UW, MELAMED RJ, SCHNAARS Y et al.: Tolerability and hormonal suppression of the LHRH -antagonist cetrorelix in patients with prostate cancer. J. Urol. (1997) 157(Suppl.) :141.
   Google Scholar
• HARNING R, MAILLIARD JA, ROSPOND R, et al.: Deslorelin (a new LHRH agonist) significantly reduces tumor flare during early treatment of Stage D2 prostate cancer. Proceedings of the Annual Meeting of the American Association of Cancer Research (1993) 34:202, A1206.
   Google Scholar
• FDC Reports: The Pink Sheet (29 November 1995).
   Google Scholar
• SHAH J, MONROE S, WOLFE L, et al.: Pharmacokinetics and pharmacodynamics of a novel GnRH antagonist (RS-26306) in humans. Pharm. Res. (1991) 8 (Suppl.):249.
   Google Scholar
• Clinical trials update. Scrip (1997) 10:2200.
   Google Scholar
• TALWAR GP: Vaccines for control of fertility and hormone-dependent cancers. Immunol. Cell Biol. (1997) 75:184–189.
   PubMed Web of Science ®Google Scholar
• DORR FA, SIKIC BI, NEMUNAITIS J, et al.: ISIS 3521/CGP 64128A-antisense to protein kinase C-alpha. Eur. J. Cancer (1997) 33(Part A, Suppl.5) :52.
   Google Scholar
• MCKEAGE MJ, RAYNAUD F, WARD J, et al.: Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer. J. Clin. Oncol. (1997) 15:2691–2700.
   PubMed Web of Science ®Google Scholar
• TYRRELL C, LIAZAL STUDY GROUPS: Liazal versus cyproterone acetate or prednisone in hormone-resistant prostate cancer: results of two clinical trials. Ann. Oncol. (1996) 7\(Suppl. 5):57.
   Google Scholar
• Clinical trials update. Scrip (1996) 21:2152.
   Google Scholar
• BOASBERG P, HARBAUGH B, ROTH B, et al.: Marimastat. A novel matrix metalloprotease inhibitor in patients with hormone refractory prostate cancer. Proc. Am. Soc. Clin. Oncol. (1996) 15:258.
   Google Scholar
• Clinical trials update. Scrip (18 July 1997) 20:2250.
   Google Scholar
• Phase I/II data with Sugen's SU101. Marketletter (26 May 1997) 24:21.
   Google Scholar
• TRAXLER PM: Protein tyrosine kinase inhibitors in cancer treatment. Exp. Opin. Ther. Patents (1997) 7:571–588.
   Web of Science ®Google Scholar
• DAWSON NA, FIGG WD, COOPER MR, et al.: Phase II trial of suramin, leuprolide and flutamide in previously untreated metastatic prostate cancer. J. Clin. Oncol. (1997) 15:1470–1477.
   PubMed Web of Science ®Google Scholar
• YODEN T, OKADA M, KAWAMINAMI E, et al.: Synthesis and biological evaluation ofnovel non-steroidal inhibitors of steroid 17,20 lyase. 213th American Chemical Society National Meeting (1997). Abstract MEDI 206.
   Google Scholar
• CARDUCCI MA, DEWEESE TL, NELSON WG, et al.: Prostate cancer treatment strategies based on tumor-specific biological principles: future directions. Semin. Oncol. (1996) 23(6 Suppl. 14):56–62.
   PubMed Web of Science ®Google Scholar